In today’s podcast, Dr. Howard Bailey will discuss human papillomavirus, or HPV, and explain why it’s associated with certain types of cancer. He also discusses HPV vaccines, and how they can help lower the risk of these cancers.
In this podcast, Dr. Michael Fisch, Dr. Melissa Accordino, and Dr. Arlene Chung discuss their article, “Using Technology to Improve Cancer Care: Social Media, Wearables, and Electronic Health Records,” and explain how doctors are using digital technology to communicate with their patients, and each other.
Cancer care has become increasingly complex, so someone with cancer will be treated by a collaborative team of health care providers that includes doctors, nurses, and a wide range of additional specialists. In today’s podcast, Wendy Vogel discusses the role of oncology advanced practitioners, or APs, as a part of this multidisciplinary team.
In today’s podcast, Lillie Shockney discusses her article, “The Value of Patient Navigators as Members of the Multidisciplinary Oncology Care Team.” Nurse navigators, also known as patient navigators, help a person with cancer “navigate” the hospital and human services bureaucracies. This includes assisting with decision making, coordinating services, and advocating for the patient with the other members of the health care team.
In today’s podcast, we will discuss direct-to-consumer genetic testing. You may have seen these at-home genetic testing kits advertised on television or the internet. Genetic testing can be used to estimate a person's risk of developing specific diseases, such as cancer. However, direct-to-consumer genetic testing may have significant limitations, and the decision to be tested for cancer risk is complex. This podcast will be led by Dr. Nadine Tung, the Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center.
Patient-reported outcomes, or PROs, are anything reported directly by the patient, such as symptoms or emotions. In today’s podcast, Dr. Lee Schwartzberg discusses his article, “Electronic Patient-Reported Outcomes: The Time Is Ripe for Integration Into Patient Care and Clinical Research,” and explains how electronic PRO systems can help improve communication between patients and their health care team.
To fast is to partially or completely reduce one’s food intake for a period of time. In today’s podcast, Suzanne Dixon and Annette Goldberg discuss the history of fasting, different types of diets, and why some scientists are researching the effects of fasting during or after cancer treatment. They also provide tips for someone considering fasting during treatment.
In today’s podcast, we will discuss new recommendations developed jointly by ASCO and the Society for Gyncologic Oncology on when women with newly diagnosed, advanced ovarian cancer should receive neoadjuvant chemotherapy, which is chemotherapy given before surgery. These recommendations are intended to help guide doctors and their patients in making treatment decisions based on current research.
In today’s podcast, ASCO’s Chief Medical Officer (2013–2021), Dr. Richard Schilsky, discusses ASCO’s first-ever clinical trial, the Targeted Agent and Profiling Utilization Registry, or TAPUR Study. The TAPUR Study is a clinical trial for people with later-stage cancer, focused on whether specific targeted therapies can benefit more patients and lead to more personalized treatments. Dr. Schilsky explains the objectives of the study, and provides information about who might be eligible to participate, as well as what is involved.
In today’s podcast, Suzanne Dixon and Annette Goldberg discuss and dispel several common myths about nutrition and cancer. Suzanne Dixon is a Registered Dietitian and Epidemiologist, with a nutrition and research consulting business in Portland, Oregon. Annette Goldberg is an Outpatient Dietitian at the Boston Medical Center Cancer Care Center.